Avalon GloboCare Corp. Files 8-K Report
Ticker: ALBT · Form: 8-K · Filed: Apr 1, 2026 · CIK: 0001630212
Sentiment: neutral
Topics: 8-K, filing, corporate-update
TL;DR
Avalon GloboCare filed an 8-K on 4/1/26. Check it for updates.
AI Summary
On April 1, 2026, Avalon GloboCare Corp. filed a Form 8-K to report other events and financial statements. The filing includes various documents related to their operations and financial reporting.
Why It Matters
This filing provides an update on Avalon GloboCare Corp.'s corporate activities and financial status, which is important for investors and stakeholders to monitor.
Risk Assessment
Risk Level: low — This filing is a routine 8-K report and does not contain specific news that would immediately impact the company's risk profile.
Key Players & Entities
- Avalon GloboCare Corp. (company) — Filer of the 8-K report
- 0001630212 (company) — CIK number for Avalon GloboCare Corp.
- 2026-04-01 (date) — Filing date and period of report
FAQ
What type of report did Avalon GloboCare Corp. file?
Avalon GloboCare Corp. filed a Form 8-K, which is a current report.
When was the 8-K filing accepted by the SEC?
The filing was accepted on 2026-04-01 at 08:30:07.
What are the main items reported in this 8-K?
This 8-K reports under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
What is the CIK number for Avalon GloboCare Corp.?
The CIK number for Avalon GloboCare Corp. is 0001630212.
What is the business address of Avalon GloboCare Corp.?
The business address is 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728.
Filing Stats: 632 words · 3 min read · ~2 pages · Grade level 13.1 · Accepted 2026-04-01 08:30:07
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share ALBT The Nasdaq Stock Mar
Filing Documents
- ea0284516-8k_avalon.htm (8-K) — 28KB
- 0001213900-26-038034.txt ( ) — 189KB
- albt-20260401.xsd (EX-101.SCH) — 3KB
- albt-20260401_lab.xml (EX-101.LAB) — 33KB
- albt-20260401_pre.xml (EX-101.PRE) — 22KB
- ea0284516-8k_avalon_htm.xml (XML) — 3KB
01 Other Information
Item 8.01 Other Information. On April 1, 2026, Avalon GloboCare Corp. (the "Company") posted the disclosure below to its social media on Stocktwits; X, yahoo finance and Reddit: "On March 30, 2026, our shareholders approved several proposals related to the Company's capital structure and financing flexibility, including authorization for the Board to implement a reverse stock split in the future, if deemed appropriate. This approval does not mean a reverse stock split is being implemented at this time. There is currently no reverse stock split planned. The authorization simply provides the Board with flexibility to act in the future if it determines it is in the best interest of the Company and its shareholders. This type of authorization is a standard governance measure designed to maintain optionality as companies evaluate strategic and corporate priorities. Avalon remains focused on executing its business strategy and advancing its ongoing initiatives." We use, and will continue to use, various social media channels, including our Stocktwits account ( https://stocktwits.com/AvalonGloboCareIR ), , our X account (https://x.com/AvalonGloboC_IR), our yahoo finance account ( https://finance.yahoo.com/quote/ALBT/community/ ) and our Reddit account (https://www.reddit.com/user/AvalonGloboCareIR/), as additional means of disclosing public information to investors, the media and others interested in the Company. It is possible that certain information we disseminate in on social media could be deemed to be material information, and we encourage investors, the media and others interested in the Company to review the business and financial information that we post on our social media channels identified above, as such information could be deemed to be material information.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AVALON GLOBOCARE CORP. Dated: April 1, 2026 By: /s/ Luisa Ingargiola Name: Luisa Ingargiola Title: Chief Financial Officer 2